Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Bull Exp Biol Med ; 172(3): 385-389, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35001303

ABSTRACT

We conducted a comparative study of the calculated indices of insulin resistance HOMA-R, Caro, FGIR, and QUICKI in 29 healthy volunteers (mean age 26.21±0.93 years) with normal body mass index (23.34±0.55 kg/m2). Among the used methods for insulin resistance assessment, QUICKI is the only method that has characteristics required for the diagnostic criterium: low variability coefficient, 100% reproducibility, and minimum coefficient of variation.


Subject(s)
Insulin Resistance , Adult , Blood Glucose , Humans , Insulin , Reproducibility of Results
2.
Bull Exp Biol Med ; 164(1): 10-14, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29124537

ABSTRACT

A cross-sectional study of universe sample of patients (N=135; mean age -49.7±0.8 years) with metabolic syndrome yielded the incidence of cardiac autonomic neuropathy of 37.5%. The pathogenetic peculiarities were revealed for the onset and development of this neuropathy. At the early stages, the progress of cardiac autonomic neuropathy closely correlated with elevation of blood glucose, while endothelial dysfunction progressing at the later period against the background of persistent hyperglycemia is viewed as an extra factor contributing to the development of this disease.


Subject(s)
Metabolic Syndrome/pathology , Peripheral Nervous System Diseases/pathology , Adult , Autonomic Nervous System/pathology , Autonomic Nervous System/physiopathology , Blood Glucose , Cross-Sectional Studies , Female , Heart Rate , Humans , Male , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Middle Aged , Peripheral Nervous System Diseases/blood , Peripheral Nervous System Diseases/physiopathology , Risk Factors , Stroke Volume
3.
Bull Exp Biol Med ; 162(1): 38-41, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27878727

ABSTRACT

In a 3-month study, 30 obese patients were assigned to lifestyle modification therapy, which is the major component of all modern strategies correcting the metabolic syndrome. The 3-month course of non-pharmacological therapy significantly diminished the major index evaluating the state of these patients, i.e., the risk of cardiovascular disasters. This therapy positively affected all the states associated with metabolic syndrome: arterial BP attained the targets in 53% patients together with normalization of their nocturnal arterial BP dipping status; the lipid panel and carbohydrate metabolic indices normalized in 46 and 44% patients, respectively; hepatic steatosis moderated in 56% patients; and the disturbances in hemostasis were annihilated in 67% patients.


Subject(s)
Caloric Restriction/methods , Cardiovascular Diseases/diet therapy , Fatty Liver/diet therapy , Metabolic Syndrome/diet therapy , Obesity/diet therapy , Risk Reduction Behavior , Adult , Blood Glucose/metabolism , Blood Pressure , Cardiovascular Diseases/blood , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/prevention & control , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cholesterol, VLDL/blood , Exercise , Fatty Liver/blood , Fatty Liver/physiopathology , Humans , Life Style , Male , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Middle Aged , Obesity/blood , Obesity/physiopathology , Prospective Studies , Triglycerides/blood
4.
Bull Exp Biol Med ; 161(2): 237-40, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27383176

ABSTRACT

ANS support of the cardiac work was assessed with analysis of heart rate variability in representative samples of patients with arterial hypertension and metabolic disturbances manifested by overweight, classes I-II obesity, compromised glucose tolerance, and type II diabetes. Initially enhanced sympathetic effects on the heart rate demonstrated no further increase during the orthostatic test in contrast to suprasegmentary influences enhanced by this test. The pronouncedness of revealed peculiarities in ANS drive to the heart correlated with metabolic disturbances, and these peculiarities attained maximum in patients with type II diabetes.


Subject(s)
Autonomic Nervous System/physiopathology , Diabetes Mellitus, Type 2/physiopathology , Hypertension/physiopathology , Obesity/physiopathology , Cross-Sectional Studies , Female , Heart Rate , Humans , Male , Middle Aged , Myocardial Contraction
5.
Bull Exp Biol Med ; 160(1): 64-7, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26608375

ABSTRACT

The role of JNK-mediated signal pathway and participation of p53 transcription factor in stimulation of realization of the growth potential of the mesenchymal precursor cells by alkaloid songorine were examined in vitro. Specific inhibitors of JNK and p53 enhanced stimulation of fibroblast colony/cluster formation and proliferative activity of mesenchymal precursor cells. Under these conditions, more pronounced effects were observed with early precursors of fibroblast CFU and in both cases were accompanied by a decrease in differentiation index of progenitor elements.


Subject(s)
Alkaloids/pharmacology , MAP Kinase Signaling System/drug effects , Mesenchymal Stem Cells/drug effects , Tumor Suppressor Protein p53/physiology , Animals , Apoptosis/drug effects , Benzothiazoles/pharmacology , Cells, Cultured , Colony-Forming Units Assay , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , MAP Kinase Signaling System/physiology , Male , Mesenchymal Stem Cells/metabolism , Mice , Mice, Inbred CBA , Protein Kinase Inhibitors/pharmacology , Toluene/analogs & derivatives , Toluene/pharmacology , Tumor Suppressor Protein p53/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...